Nothing to spook investors, says CSL
Blood products giant CSL says current-year earnings should come in 10-13 per cent higher, despite its moves to taper capital expenditure. Here’s your health wrap.
Stockhead
WCN targets Canadian copper
White Cliff Minerals spots three new targets at its Rae project on the trail of district scale sediment-hosted copper.
Zeotech signs Holcim MoU
Zeotech and Holcim Australia will collaborate on advancing the manufacturing of high reactivity metakaolin and its use in concrete production.
Zeotech’s James Marsh chats fresh deal with Holcim Australia
Zeotech’s CEO James Marsh joins Sarah Hughan on Stockhead TV to talk about the company’s memorandum of understanding to advance metakaolin production.
More Stories
Putting the bull in bullion
Gold stocks ripped up the ASX small caps scene for September as bullion kept punching through all-time highs.
All you need to know before the ASX opens
Here’s everything you need to know, and some things you don’t, before the ASX flies into action on Thursday.
Western Yilgarn starts exploring Ida Holmes
Several exciting exploration targets have cropped up from an airborne electromagnetic pass over of Western Yilgarn’s Ida Holmes Junction and Hells Gate prospects.
Software out in front as tech surge continues
The ASX 200 information technology sector rose 7.42% in September to remain the bourse’s top performer this year, with software, not hardware, leading the charge.
Break it Down: archTIS’ Defence deal
Today’s Break it Down details a $2.3M contract extension from archTIS for its data security offerings.
Closing Bell: Oil stocks, gold up amid conflict
As conflict escalates in the Middle East, oil stocks are surging while gold shines as a safe haven for investors.
GIM reviews interest drop for Aussie bonds
GIM Trading review identifies low-interest market as the time to shift to safe and high-return rewards
Miners climb again thanks to China
China’s stimulus measures continue to see mining stocks rise in Australia. Also in the news: coal funding and an update on the Paladin merger.
Challenger Gold targets producer status in 2025
A toll treatment deal supported by a $6.6m private placement will see Challenger Gold leverage record gold prices at its Hualilan project in Argentina.
Potash slice a sweet treat for Reward
Reward Minerals has jumped on a $2.13m Beyondie SOP plant purchase as BPM shares claw up the charts on Mt Gibson gold nearology. Here’s your resources wrap.
Original URL: https://www.themercury.com.au/business/stockhead/page/75